Outcome Measures in Clinical Trials for Multiple Sclerosis.
about
Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.Resolving the clinico-radiological paradox in multiple sclerosis.Preventing disability in inflammatory bowel disease.Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis.Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.Establishing pathological cut-offs for lateral ventricular volume expansion rates.Functional Connectivity in Multiple Sclerosis: Recent Findings and Future Directions
P2860
Q41476817-6E7E07C1-FC2B-4525-A959-F3831E4A4C4DQ43297894-EB6B00C0-225F-4ECA-9C25-2AB34BE64781Q45338711-C2B3154E-9B49-4917-8EA6-50A601909B5EQ47693137-3EA5565C-7EF0-487B-B108-E1E8870BA0DEQ47947804-E8845180-D5A3-4D43-9429-DA93C43C8C68Q52661563-14EDB6A2-5227-431C-B2EA-8AF1B0D5CE83Q58573154-4507D45D-897A-4BC6-B378-1D9497C3B4DF
P2860
Outcome Measures in Clinical Trials for Multiple Sclerosis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Outcome Measures in Clinical Trials for Multiple Sclerosis.
@en
type
label
Outcome Measures in Clinical Trials for Multiple Sclerosis.
@en
prefLabel
Outcome Measures in Clinical Trials for Multiple Sclerosis.
@en
P2860
P1433
P1476
Outcome Measures in Clinical Trials for Multiple Sclerosis
@en
P2093
Bernard M J Uitdehaag
P2860
P2888
P304
P356
10.1007/S40263-017-0412-5
P5008
P577
2017-03-01T00:00:00Z
P6179
1083738806